Clinical studyBlood thrombogenicity in type 2 diabetes mellitus patients is associated with glycemic control☆
Under an Elsevier user license
open archive
Abbreviations
ANOVA
analysis of variance
CRP
C-reactive protein
HbA1c
hemoglobin A1c
MANOVA
multivariate analysis of variance
PAI-1
plasminogen activator inhibitor 1
RM-ANOVA
repeated measures ANOVA
T2DM
type 2 diabetes mellitus
Cited by (0)
- ☆
This study was supported by a grant from the Spanish Society of Cardiology, Madrid, Spain (JIO), the National Institutes of Health (Bethesda, Maryland) grant NIH-P50HL54467-SCOR in thrombosis to Dr. Juan J. Badimon, the National Center for Research Resources (5M01RR0071) (Bethesda, Maryland) and from Pfizer (Morris Plains, New Jersey).
Copyright © 2001 American College of Cardiology. Published by Elsevier Inc. All rights reserved.